Name: Mass Spectrometry Market by Product [Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software, Services], Inlet Type (LC-MS, GC-MS, ICP-MS, Other Inlet Types), Application (Omics, Drug Discovery, Food, Environmental), End User (Pharma, Biotech) - Global Forecast to 2031
Brand: MarketsandMarkets
SKU: AST3787
Price: 4950 USD
Availability: InStock

報告摘要

The global mass spectrometry market is projected to reach USD 10,783.3 million by 2031 from USD 7,074.0 million in 2026, at a CAGR of 8.8% from 2026 to 2031. The global mass spectrometry market is experiencing strong growth driven by the rapid expansion of precision medicine, biologics development, multi-omics research, and regulatory-driven bioanalytical testing across pharmaceutical, biotechnology, clinical diagnostics, food safety, and environmental sectors. One of the latest trends accelerating market growth is the increasing adoption of high-resolution LC-MS/MS and hybrid mass spectrometry platforms integrated with AI-enabled analytics, automation, cloud-connected laboratory workflows, and robotic sample preparation to improve throughput, reproducibility, and operational efficiency. Pharmaceutical and biopharmaceutical companies are heavily investing in advanced mass spectrometry systems for biomarker discovery, antibody-drug conjugate (ADC) characterization, cell and gene therapy development, and FDA-compliant pharmacokinetic analysis, while hospitals and diagnostic laboratories are increasingly deploying benchtop clinical LC-MS/MS systems for endocrinology, toxicology, and precision oncology testing. Additionally, the rapid growth of outsourced bioanalytical services through CROs, increasing PFAS and environmental contaminant testing, and the transition toward digitally integrated and standardized analytical ecosystems are further strengthening global demand for next-generation hybrid and high-throughput mass spectrometry platforms. The instruments segment accounted for the largest share of the mass spectrometry market. By product, the mass spectrometry market is segmented into instruments, software, and services. During the forecast period, the instruments segment is projected to hold the largest share of the mass spectrometry market owing to increasing investments in advanced analytical technologies across pharmaceutical, biotechnology, clinical research, and multi-omics applications. The growing demand for high-performance mass spectrometry instruments is being driven by the rising complexity of drug development workflows involving biologics, antibody-drug conjugates (ADCs), cell and gene therapies, and precision medicine initiatives. Pharmaceutical and biopharmaceutical companies are increasingly investing in next-generation mass spectrometry platforms with improved sensitivity, high-resolution analysis, automation, and AI-enabled workflow capabilities to enhance bioanalytical efficiency, accelerate research timelines, and ensure regulatory compliance. Furthermore, developed regions such as North America and Europe are witnessing faster instrument replacement and upgrade cycles due to continuous technological innovation and the increasing adoption of high-throughput analytical systems across research laboratories, hospitals, and clinical institutions. “The LC-MS segment accounted for the largest share of the mass spectrometry market.” By inlet type, the mass spectrometry market is segmented into GC-MS, LC-MS, ICP-MS, and other inlet types. During the forecast period, the LC-MS segment is expected to dominate the global mass spectrometry market owing to its widespread adoption across pharmaceutical, biotechnology, clinical diagnostics, food safety, and environmental testing applications. LC-MS is one of the most extensively utilized analytical techniques for the identification and quantification of complex biological and chemical compounds with high sensitivity and accuracy. The segment is witnessing significant growth due to increasing regulatory acceptance, expanding biologics and precision medicine research, and rising demand for advanced bioanalytical testing workflows. One of the major market trends driving LC-MS adoption is the implementation of ICH M10 bioanalytical method validation guidelines by the U.S. Food and Drug Administration and other international regulatory agencies, which recognize LC-MS/MS as the preferred technology for pharmacokinetic analysis, biomarker quantification, and regulated drug testing. This regulatory shift is encouraging pharmaceutical companies and contract research organizations to increase investments in next-generation LC-MS/MS platforms to support clinical development, regulatory compliance, and high-throughput drug analysis applications. “The pharma/biopharma manufacturing application segment accounted for the largest share of the mass spectrometry market.” The pharmaceutical and biopharmaceutical sectors are emerging as major application areas and key news trends in the mass spectrometry market due to the growing demand for advanced analytical technologies in drug discovery, biologics characterization, biomarker identification, and GMP-compliant quality control. Pharmaceutical companies are increasingly adopting LC-MS/MS and high-resolution mass spectrometry systems to support complex biologics, antibody-drug conjugates, peptides, cell and gene therapies, and biosimilar development, where traditional analytical methods are often insufficient. The rising focus on precision medicine, regulatory compliance, impurity profiling, and real-time process monitoring is further accelerating the adoption of advanced mass spectrometry platforms across pharmaceutical R&D and manufacturing operations. In addition, the rapid expansion of omics research, proteomics, metabolomics, and personalized medicine is driving continuous innovation and product launches in the mass spectrometry industry. Leading companies are introducing automated, high-throughput, and AI-enabled mass spectrometry solutions to support translational research and biopharma workflows. The increasing outsourcing of bioanalytical testing to CROs and CDMOs, along with growing investments in biologics and advanced therapies, is further strengthening the role of mass spectrometry in pharmaceutical and biotechnology applications. These trends are positioning pharma and biopharma as the fastest-growing and highest-revenue-generating application segments within the global mass spectrometry market. By end-user, the pharmaceutical companies segment is projected to account for the largest market share during the forecast period. By end user, the mass spectrometry market is segmented into pharmaceutical companies, biotechnology companies, research laboratories & academic institutes, environmental testing laboratories, food & beverage industry, hospital clinical & forensic laboratories, petrochemical industry, and other end users. During the forecast period, the pharmaceutical companies segment is expected to register the fastest growth owing to the increasing adoption of advanced analytical technologies in biologics development, precision therapeutics, and multi-omics–based drug discovery workflows. One of the major trends driving growth in this segment is the rising deployment of advanced hybrid mass spectrometry platforms such as Orbitrap, Q-TOF, Triple Quadrupole Linear Ion Trap, and FT-MS systems for complex biologic characterization, antibody-drug conjugate (ADC) analysis, host-cell protein monitoring, and real-time process analytical technology (PAT) applications. Pharmaceutical and biopharmaceutical manufacturers are increasingly integrating high-resolution hybrid MS systems into manufacturing, quality control, and bioanalytical environments to support continuous bioprocessing, impurity profiling, glycosylation studies, and ultra-trace contaminant detection. This trend is particularly prominent in monoclonal antibody, mRNA, and cell therapy manufacturing facilities, where next-generation therapeutics require highly sensitive and high-resolution analytical capabilities beyond conventional testing technologies. “Asia Pacific is projected to show the highest growth rate in the mass spectrometry market.” The mass spectrometry market spans five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific mass spectrometry market is witnessing rapid transformation driven by the expansion of biologics manufacturing, multi-omics research, precision medicine programs, and large-scale pharmaceutical outsourcing across China, India, Japan, South Korea, and Southeast Asia. One of the latest trends is the increasing deployment of high-resolution hybrid LC-MS/MS, Orbitrap, and Q-TOF systems in CROs, CDMOs, and biopharmaceutical manufacturing facilities for advanced biologic characterization, impurity profiling, glycan analysis, and cell & gene therapy workflows. Governments across the region are heavily investing in genomics, proteomics, metabolomics, and translational medicine initiatives, accelerating the adoption of AI-enabled and cloud-connected mass spectrometry platforms in both research and clinical diagnostics environments. Another major trend reshaping the region is the rapid digitalization of analytical laboratories through robotic sample preparation, laboratory information system (LIS) integration, and automated bioanalytical workflows to support high-throughput drug development and regulatory compliance. Additionally, APAC is emerging as a global pharmaceutical and bioanalytical outsourcing hub, creating strong recurring demand for advanced LC-MS infrastructure among CROs and contract testing laboratories. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%) • By Designation: C-level Executives (35%), Directors (25%), and Others (40%) • By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East & Africa (5%) The major players in the mass spectrometry market include Thermo Fisher Scientific (US), Agilent Technologies (US), Sciex (US), Waters Corporation (US), Bruker (US), Shimadzu Corporation (Japan), and PerkinElmer Inc. (US), among others. Research Coverage The research report examines the mass spectrometry market by product, inlet type, application, end users, and region. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micro-market analysis. Reasons to Buy the Report The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall mass spectrometry market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities. This report provides insightful data on the following pointers: • Market Penetration: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market • Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market • Market Development: Insightful data on profitable developing areas • Market Diversification: Details about recent developments and advancements in the mass spectrometry market • Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors

目錄 Table of Contents

1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 MARKET SCOPE 27 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 27 1.3.2 INCLUSIONS AND EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 29 1.4 CURRENCY CONSIDERED 29 1.5 STAKEHOLDERS 29 1.6 SUMMARY OF CHANGES 30 2 EXECUTIVE SUMMARY 31 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 31 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 32 2.3 DISRUPTIVE TRENDS IN MASS SPECTROMETRY MARKET 33 2.4 HIGH-GROWTH SEGMENTS 34 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 35 3 PREMIUM INSIGHTS 36 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MASS SPECTROMETRY MARKET 36 3.2 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY INLET TYPE AND COUNTRY 37 3.3 MASS SPECTROMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38 4 MARKET OVERVIEW 39 4.1 INTRODUCTION 39 4.2 MARKET DYNAMICS 39 4.2.1 DRIVERS 40 4.2.1.1 Precision medicine & biomarker-driven healthcare system to drive adoption 40 4.2.1.2 Adoption of send‑out tests to control turnaround and cost 40 4.2.1.3 Increased privatization of environmental services and regulatory framework 40 4.2.1.4 Increasing investments in pharmaceutical research & development 41 4.2.2 RESTRAINTS 41 4.2.2.1 Capital-intensive investments for high-end equipment 41 4.2.2.2 Time-consuming sample preparation steps 42 4.2.3 OPPORTUNITIES 42 4.2.3.1 Growing application of mass spectrometry in clinical and forensic settings 42 4.2.3.2 Expansion of microbiome and infection diagnostics 42 4.2.3.3 Development of novel mass sensors and nanopore ion sources 42 4.2.4 CHALLENGES 43 4.2.4.1 Software interoperability and data management fragmentation 43 4.2.4.2 Inadequate infrastructure and shortage of skilled professionals 43 4.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 43 4.4 UNMET NEEDS 44 4.5 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 44 4.6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 44 5 INDUSTRY TRENDS 46 5.1 PORTER’S FIVE FORCES ANALYSIS 46 5.1.1 BARGAINING POWER OF SUPPLIERS 47 5.1.2 BARGAINING POWER OF BUYERS 47 5.1.3 THREAT OF NEW ENTRANTS 47 5.1.4 THREAT OF SUBSTITUTES 47 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 47 5.2 MACROECONOMIC OUTLOOK 48 5.2.1 INTRODUCTION 48 5.2.2 GDP TRENDS AND FORECAST 48 5.2.3 TRENDS IN MASS SPECTROMETRY INDUSTRY 48 5.3 VALUE CHAIN ANALYSIS 48 5.3.1 R&D 49 5.3.2 RAW MATERIAL PROCUREMENT 49 5.3.3 MANUFACTURING 50 5.3.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 50 5.4 ECOSYSTEM ANALYSIS 50 5.5 PRICING ANALYSIS 51 5.5.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 52 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 53 5.6 TRADE ANALYSIS 56 5.6.1 IMPORT SCENARIO (HS CODE 902781) 56 5.6.2 EXPORT SCENARIO (HS CODE 902781) 57 5.7 KEY CONFERENCES AND EVENTS, 2026–2027 58 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58 5.9 INVESTMENT AND FUNDING SCENARIO 59 5.10 CASE STUDY ANALYSIS 61 5.11 IMPACT OF 2025 US TARIFF – MASS SPECTROMETRY MARKET 61 5.11.1 INTRODUCTION 61 5.11.2 KEY TARIFF RATES 62 5.11.3 PRICE IMPACT ANALYSIS 62 5.11.4 IMPACT ON COUNTRIES/REGIONS 63 5.11.4.1 US 63 5.11.4.2 Europe 63 5.11.4.3 Asia Pacific 63 5.11.5 IMPACT ON END-USE INDUSTRIES 63 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS 64 6.1 TECHNOLOGICAL ANALYSIS 64 6.1.1 KEY TECHNOLOGIES 64 6.1.1.1 Miniaturized ion trap and quadrupole mass analyzer 64 6.1.1.2 Quadrupole mass analyzer 64 6.1.1.3 Time-of-flight mass analyzer 64 6.1.1.4 Ion trap mass analyzer 65 6.1.2 COMPLEMENTARY TECHNOLOGIES 65 6.1.2.1 LC-MS 65 6.1.2.2 IOT sensor integration and environmental monitoring networks 65 6.1.3 ADJACENT TECHNOLOGIES 65 6.1.3.1 Mass spectrometry imaging 65 6.1.3.2 Ion mobility spectrometry 65 6.2 PATENT ANALYSIS 66 6.3 IMPACT OF AI ON MASS SPECTROMETRY MARKET 67 6.3.1 TOP USE CASES AND MARKET POTENTIAL 67 6.3.2 KEY COMPANIES IMPLEMENTING AI 68 6.3.3 BEST PRACTICES IN MASS SPECTROMETRY MARKET 68 6.3.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS 69 6.3.5 CLIENTS' READINESS TO ADOPT AI IN MASS SPECTROMETRY 69 6.4 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 69 7 REGULATORY LANDSCAPE 70 7.1 REGIONAL REGULATIONS AND COMPLIANCE 70 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 7.1.2 REGULATORY SCENARIO 73 7.1.2.1 North America 73 7.1.2.2 Europe 73 7.1.2.3 Asia Pacific 73 7.1.2.4 Rest of the World 73 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 74 8.1 DECISION-MAKING PROCESS 74 8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 74 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 74 8.2.2 KEY BUYING CRITERIA 75 8.3 UNMET NEEDS OF END USERS 76 8.4 MARKET PROFITABILITY 76 9 MASS SPECTROMETRY MARKET, BY OFFERING 77 9.1 INTRODUCTION 78 9.2 INSTRUMENTS 78 9.2.1 HYBRID MASS SPECTROMETRY INSTRUMENTS 79 9.2.1.1 Triple quadrupole MS 80 9.2.1.1.1 Enhanced selectivity, better accuracy, and greater reproducibility to drive adoption 80 9.2.1.2 Quadrupole-time of flight (Q-TOF) MS 81 9.2.1.2.1 Latest advances in Q-TOF mass spectrometry technology to streamline workflow, making it more efficient 81 9.2.1.3 Fourier transform MS 82 9.2.1.3.1 High-resolution biomolecule analysis to drive adoption 82 9.2.2 SINGLE MASS SPECTROMETRY INSTRUMENTS 83 9.2.2.1 Quadrupole MS 84 9.2.2.1.1 Wide application base in industry and academia to boost market growth 84 9.2.2.2 Time-of-flight MS 85 9.2.2.2.1 More precise results in proteomics and conventional analytical studies to favor adoption 85 9.2.2.3 Ion trap MS 86 9.2.2.3.1 More accurate results on higher mass-to-charge ratio extensions to favor adoption in specialized studies 86 9.2.3 OTHER MASS SPECTROMETRY INSTRUMENTS 87 9.3 SOFTWARE & SERVICES 88 9.3.1 NEED FOR EFFICIENT DATA MANAGEMENT AND PROCESSING TO PROPEL MARKET 88 10 MASS SPECTROMETRY MARKET, BY INLET TYPE 90 10.1 INTRODUCTION 91 10.2 LC-MS 92 10.2.1 REGULATORY SHIFTS WILL DRIVE ADOPTION OF LC-MS IN ENVIRONMENTAL TESTING 92 10.3 GC-MS 93 10.3.1 STANDARDIZED METHODS AND REGULATORY REFORMS FOR VOLATILE ORGANIC MOLECULES TO INCREASE ADOPTION OF GC-MS 93 10.4 ICP-MS 94 10.4.1 SIMPLE SAMPLE PREPARATION AND HIGH THROUGHPUT TO DRIVE GROWTH 94 10.5 OTHER INLET TYPES 95 11 MASS SPECTROMETRY MARKET, BY APPLICATION 97 11.1 INTRODUCTION 98 11.2 OMICS RESEARCH 98 11.2.1 RECENT ADVANCEMENTS IN BIOLOGICAL RESEARCH, PARTICULARLY IN PROTEOMICS AND GENOMICS, TO DRIVE MARKET 98 11.3 DRUG DISCOVERY 99 11.3.1 NEED FOR HIGHER EFFICACY AND PRODUCT QUALITY TO SUPPORT GROWTH 99 11.4 ENVIRONMENTAL TESTING 101 11.4.1 INCREASING NEED FOR MONITORING WATER CONTAMINATION TO PROPEL MARKET 101 11.5 FOOD TESTING 102 11.5.1 INCREASING IMPORTANCE OF SAFETY STANDARDS TO AMPLIFY GROWTH 102 11.6 PHARMA/BIOPHARMA MANUFACTURING 103 11.6.1 RISING USE OF MASS SPECTROMETRY IN PESTICIDE RESIDUE ANALYSIS, PROTEIN IDENTIFICATION, AND CARBON DATING TO AID GROWTH 103 11.7 CLINICAL DIAGNOSTICS 104 11.7.1 GROWING USE OF MASS SPECTROMETRY IN DRUG MONITORING, TOXICOLOGY, AND ENDOCRINOLOGY TO DRIVE MARKET 104 11.8 APPLIED SCIENCES 105 11.8.1 NEED FOR QUALITY CONTROL IN SEMICONDUCTOR INDUSTRY TO SUPPORT GROWTH 105 11.9 OTHER APPLICATIONS 106 12 MASS SPECTROMETRY MARKET, BY END USER 107 12.1 INTRODUCTION 108 12.2 PHARMACEUTICAL COMPANIES 108 12.2.1 GROWTH IN PHARMACEUTICAL SECTOR WILL FUEL DEMAND FOR MASS SPECTROMETRY 108 12.3 BIOTECHNOLOGY COMPANIES 109 12.3.1 GROWING BIOPHARMACEUTICAL APPLICATIONS TO DRIVE MARKET 109 12.4 RESEARCH LABS & ACADEMIC INSTITUTES 110 12.4.1 BREAKTHROUGH DEVELOPMENTS AND INDUSTRY-ACADEMIA PARTNERSHIPS TO PROPEL MARKET 110 12.5 ENVIRONMENTAL TESTING LABS 111 12.5.1 NEW AMENDMENTS IN ENVIRONMENTAL LAWS AND PRIVATIZATION OF TESTING SERVICES TO DRIVE MARKET 111 12.6 FOOD & BEVERAGE INDUSTRY 112 12.6.1 GROWING FOOD SAFETY CONCERNS TO SUPPORT MARKET GROWTH 112 12.7 FORENSIC LABS 113 12.7.1 ADVANCEMENTS IN TECHNOLOGY AND STRICT LAWS TO CREATE OPPORTUNITIES FOR MASS SPECTROMETRY 113 12.8 PETROCHEMICAL INDUSTRY 114 12.8.1 GROWING NUMBER OF NEW OIL & GAS FIELDS TO PROPEL MARKET 114 12.9 OTHER END USERS 115 13 MASS SPECTROMETRY MARKET, BY REGION 117 13.1 INTRODUCTION 118 13.2 NORTH AMERICA 119 13.2.1 US 123 13.2.1.1 Increased government investments and research funding to drive market 123 13.2.2 CANADA 125 13.2.2.1 Growing focus on clean energy technology to propel market 125 13.3 EUROPE 126 13.3.1 GERMANY 130 13.3.1.1 Growing pharmaceutical industry to drive market 130 13.3.2 UK 132 13.3.2.1 Industry academia partnerships to drive market 132 13.3.3 FRANCE 134 13.3.3.1 Strong environmental policies and public-funded research programs to drive demand 134 13.3.4 ITALY 135 13.3.4.1 Growing utilization of mass spectrometry among pharmaceutical and biotechnology end-use industries to drive market 135 13.3.5 SPAIN 137 13.3.5.1 Strong environmental monitoring framework to drive market 137 13.3.6 REST OF EUROPE 139 13.4 ASIA PACIFIC 140 13.4.1 JAPAN 145 13.4.1.1 Strong research infrastructure to drive demand for advanced MS models 145 13.4.2 CHINA 147 13.4.2.1 Increasing investments in scientific R&D to advance growth 147 13.4.3 INDIA 149 13.4.3.1 Increased government investments to drive market 149 13.4.4 SOUTH KOREA 151 13.4.4.1 Large industrial application base to drive demand for mass spectrometry 151 13.4.5 AUSTRALIA 153 13.4.5.1 Increasing focus on early cancer diagnosis and development of RNA therapies to aid growth 153 13.4.6 REST OF ASIA PACIFIC 155 13.5 LATIN AMERICA 156 13.5.1 BRAZIL 160 13.5.1.1 Increased local agricultural manufacturing to drive market growth 160 13.5.2 MEXICO 161 13.5.2.1 Growth in local manufacturing for pharmaceuticals to drive market 161 13.5.3 REST OF LATIN AMERICA 163 13.6 MIDDLE EAST & AFRICA 165 13.6.1 GCC COUNTRIES 168 13.6.1.1 Favorable government initiatives to support market growth 168 13.6.2 REST OF MIDDLE EAST & AFRICA 170 14 COMPETITIVE LANDSCAPE 172 14.1 OVERVIEW 172 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 172 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MASS SPECTROMETRY MARKET, JANUARY 2022–JUNE 2026 173 14.3 REVENUE ANALYSIS, 2021–2025 174 14.4 MARKET SHARE ANALYSIS, 2025 174 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 176 14.5.1 STARS 176 14.5.2 EMERGING LEADERS 177 14.5.3 PERVASIVE PLAYERS 177 14.5.4 PARTICIPANTS 177 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 178 14.5.5.1 Company footprint 178 14.5.5.2 Offering footprint 179 14.5.5.3 Application footprint 180 14.5.5.4 End-user footprint 181 14.5.5.5 Region footprint 182 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 183 14.6.1 PROGRESSIVE COMPANIES 183 14.6.2 RESPONSIVE COMPANIES 183 14.6.3 DYNAMIC COMPANIES 183 14.6.4 STARTING BLOCKS 183 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 185 14.6.5.1 Detailed list of key startups/SMEs, 2025 185 14.6.5.2 Competitive benchmarking of key startups/SMEs 186 14.7 COMPANY VALUATION & FINANCIAL METRICS 187 14.7.1 FINANCIAL METRICS 187 14.7.2 COMPANY VALUATION 188 14.8 BRAND COMPARISON 189 14.9 COMPETITIVE SCENARIO 190 14.9.1 PRODUCT LAUNCHES 190 14.9.2 DEALS 192 14.9.3 EXPANSIONS 193 15 COMPANY PROFILES 195 15.1 KEY PLAYERS 195 15.1.1 AGILENT TECHNOLOGIES, INC. 195 15.1.1.1 Business overview 195 15.1.1.2 Products offered 196 15.1.1.3 Recent developments 199 15.1.1.3.1 Product launches & approvals 199 15.1.1.3.2 Deals 200 15.1.1.3.3 Expansions 201 15.1.1.4 MnM view 201 15.1.1.4.1 Right to win 201 15.1.1.4.2 Strategic choices 202 15.1.1.4.3 Weaknesses & competitive threats 202 15.1.2 THERMO FISHER SCIENTIFIC INC. 203 15.1.2.1 Business overview 203 15.1.2.2 Products offered 204 15.1.2.3 Recent developments 206 15.1.2.3.1 Product launches 206 15.1.2.3.2 Deals 207 15.1.2.3.3 Expansions 209 15.1.2.4 MnM view 209 15.1.2.4.1 Right to win 209 15.1.2.4.2 Strategic choices 209 15.1.2.4.3 Weaknesses & competitive threats 210 15.1.3 WATERS CORPORATION 211 15.1.3.1 Business overview 211 15.1.3.2 Products Offered 212 15.1.3.3 Recent developments 214 15.1.3.3.1 Product launches 214 15.1.3.3.2 Deals 215 15.1.3.3.3 Expansions 216 15.1.3.4 MnM view 216 15.1.3.4.1 Right to win 216 15.1.3.4.2 Strategic choices 216 15.1.3.4.3 Weaknesses & competitive threats 216 15.1.4 DANAHER CORPORATION 217 15.1.4.1 Business overview 217 15.1.4.2 Products offered 218 15.1.4.3 Recent developments 220 15.1.4.3.1 Product launches 220 15.1.4.3.2 Deals 221 15.1.4.3.3 Expansions 221 15.1.4.4 MnM view 222 15.1.4.4.1 Right to win 222 15.1.4.4.2 Strategic choices 222 15.1.4.4.3 Weaknesses & competitive threats 222 15.1.5 BRUKER CORPORATION 223 15.1.5.1 Business overview 223 15.1.5.2 Products offered 224 15.1.5.3 Recent developments 226 15.1.5.3.1 Product launches & approvals 226 15.1.5.3.2 Deals 227 15.1.5.3.3 Expansions 228 15.1.5.3.4 Other developments 228 15.1.5.4 MnM view 229 15.1.5.4.1 Right to win 229 15.1.5.4.2 Strategic choices 229 15.1.5.4.3 Weaknesses & competitive threats 229 15.1.6 SHIMADZU CORPORATION 230 15.1.6.1 Business overview 230 15.1.6.2 Products offered 231 15.1.6.3 Recent developments 233 15.1.6.3.1 Product launches 233 15.1.6.3.2 Deals 234 15.1.6.3.3 Expansions 235 15.1.7 MKS INC. 236 15.1.7.1 Business overview 236 15.1.7.2 Products offered 237 15.1.8 PERKINELMER, INC. 238 15.1.8.1 Business overview 238 15.1.8.2 Products offered 239 15.1.8.3 Recent developments 240 15.1.8.3.1 Product launches 240 15.1.8.3.2 Deals 241 15.1.9 JEOL LTD 242 15.1.9.1 Business overview 242 15.1.9.2 Products offered 243 15.1.10 HITACHI HIGH-TECH CORPORATION 244 15.1.10.1 Business overview 244 15.1.10.2 Products offered 245 15.1.10.3 Recent developments 246 15.1.10.3.1 Other developments 246 15.1.11 TELEDYNE TECHNOLOGIES INCORPORATED 247 15.1.11.1 Business overview 247 15.1.11.2 Products offered 248 15.1.11.3 Recent developments 249 15.1.11.3.1 Product launches 249 15.1.11.3.2 Deals 249 15.1.12 AMETEK, INC. 250 15.1.12.1 Business overview 250 15.1.12.2 Products offered 251 15.1.12.3 Recent developments 252 15.1.12.3.1 Deals 252 15.1.13 JASCO 253 15.1.13.1 Business overview 253 15.1.13.2 Products offered 253 15.1.14 F. HOFFMANN-LA ROCHE LTD. 254 15.1.14.1 Business overview 254 15.1.14.2 Products offered 255 15.1.14.3 Recent developments 256 15.1.14.3.1 Product launches 256 15.1.14.3.2 Expansions 256 15.2 OTHER PLAYERS 257 15.2.1 ANALYTIK JENA GMBH 257 15.2.2 HIDEN ANALYTICAL 258 15.2.3 LECO CORPORATION 259 15.2.4 RIGAKU HOLDINGS CORPORATION 260 15.2.5 YOUNGIN CHROMASS 261 15.2.6 SCION INSTRUMENTS 262 15.2.7 KORE TECHNOLOGY 263 15.2.8 PROCESS INSIGHTS, INC. 264 15.2.9 MASSTECH 265 15.2.10 ADVION, INC. 266 15.2.11 SPACETEK TECHNOLOGY AG 266 15.2.12 ELEMENTAR ANALYSENSYSTEME GMBH 267 15.2.13 SKYRAY INSTRUMENTS USA, INC. 268 15.2.14 MICROSAIC SYSTEMS PLC 269 15.2.15 PFEIFFER VACUUM GMBH 270 16 RESEARCH METHODOLOGY 271 16.1 RESEARCH DATA 271 16.1.1 SECONDARY RESEARCH 272 16.1.1.1 Key secondary sources 274 16.1.1.2 Key data from secondary sources 274 16.1.2 PRIMARY RESEARCH 275 16.1.2.1 Key primary sources 275 16.1.2.2 Key supply- and demand-side participants 275 16.1.2.3 Breakdown of primary interviews 276 16.1.2.4 Key primary insights 277 16.2 MARKET SIZE ESTIMATION METHODOLOGY 277 16.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 279 16.2.2 END-USER-BASED MAPPING MARKET ESTIMATION 280 16.3 GROWTH FORECASTING MODEL 282 16.4 DATA TRIANGULATION AND MARKET BREAKDOWN 283 16.5 RESEARCH ASSUMPTIONS 284 16.6 RESEARCH LIMITATIONS 284 16.7 RISK ANALYSIS 285 17 APPENDIX 286 17.1 DISCUSSION GUIDE 286 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 291 17.3 CUSTOMIZATION OPTIONS 293 17.4 RELATED REPORTS 293 17.5 AUTHOR DETAILS 294

圖表清單 List of Tables & Figures

TABLE 1 MASS SPECTROMETRY MARKET: INCLUSIONS AND EXCLUSIONS OF STUDY 28 TABLE 2 MASS SPECTROMETRY MARKET: UNMET NEEDS 44 TABLE 3 STRATEGIC FOCUS OF TIER-1/2/3 PLAYERS 45 TABLE 4 MASS SPECTROMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 46 TABLE 5 MASS SPECTROMETRY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 51 TABLE 6 AVERAGE SELLING PRICING TREND OF MASS SPECTROMETERS, BY KEY PLAYER, 2023–2025 (USD THOUSAND) 53 TABLE 7 AVERAGE SELLING PRICING TREND OF MASS SPECTROMETERS, BY REGION, 2023–2025 (USD THOUSAND) 55 TABLE 8 IMPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 56 TABLE 9 EXPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 57 TABLE 10 MASS SPECTROMETRY MARKET: LIST OF MAJOR CONFERENCES AND EVENTS IN 2026–2027 58 TABLE 11 CASE STUDY 1: THERMO FISHER SCIENTIFIC – ORBITRAP ASTRAL ZOOM 61 TABLE 12 CASE STUDY 2: AGILENT TECHNOLOGIES - INFINITYLAB PRO IQ SERIES 61 TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES 62 TABLE 14 MASS SPECTROMETRY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024–2026 67 TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 TABLE 18 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 19 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 75 TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 76 TABLE 22 MASS SPECTROMETRY MARKET: LIST OF UNMET NEEDS 76 TABLE 23 MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 78 TABLE 24 MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 79 TABLE 25 MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 79 TABLE 26 HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 80 TABLE 27 HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 80 TABLE 28 TRIPLE QUADRUPOLE MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 81 TABLE 29 Q-TOF MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 82 TABLE 30 FOURIER TRANSFORM MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 83 TABLE 31 SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 84 TABLE 32 SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 84 TABLE 33 QUADRUPOLE MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 85 TABLE 34 TIME-OF-FLIGHT MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 86 TABLE 35 ION TRAP MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 87 TABLE 36 OTHER MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 88 TABLE 37 MASS SPECTROMETRY MARKET FOR SOFTWARE & SERVICES, BY REGION, 2024–2031 (USD MILLION) 89 TABLE 38 MASS SPECTROMETRY MARKET, BY INLET TYPE, 2024–2031 USD MILLION) 91 TABLE 39 MASS SPECTROMETRY MARKET FOR LC-MS, BY REGION, 2024–2031 (USD MILLION) 93 TABLE 40 MASS SPECTROMETRY MARKET FOR GC-MS, BY REGION, 2024–2031 (USD MILLION) 94 TABLE 41 MASS SPECTROMETRY MARKET FOR ICP-MS, BY REGION, 2024–2031 USD MILLION) 95 TABLE 42 MASS SPECTROMETRY MARKET FOR OTHER INLET TYPES, BY REGION, 2024–2031 (USD MILLION) 96 TABLE 43 MASS SPECTROMETRY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 98 TABLE 44 MASS SPECTROMETRY MARKET FOR OMICS RESEARCH, BY REGION, 2024–2031 (USD MILLION) 99 TABLE 45 MASS SPECTROMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2024–2031 (USD MILLION) 100 TABLE 46 MASS SPECTROMETRY MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2024–2031 (USD MILLION) 101 TABLE 47 MASS SPECTROMETRY MARKET FOR FOOD TESTING, BY REGION, 2024–2031 (USD MILLION) 102 TABLE 48 MASS SPECTROMETRY MARKET FOR PHARMA/BIOPHARMA MANUFACTURING, BY REGION, 2024–2031 (USD MILLION) 103 TABLE 49 MASS SPECTROMETRY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION) 104 TABLE 50 MASS SPECTROMETRY MARKET FOR APPLIED SCIENCES, BY REGION, 2024–2031 (USD MILLION) 105 TABLE 51 MASS SPECTROMETRY MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 106 TABLE 52 MASS SPECTROMETRY MARKET, BY END USER, 2024–2031 (USD MILLION) 108 TABLE 53 MASS SPECTROMETRY MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2024–2031 (USD MILLION) 109 TABLE 54 MASS SPECTROMETRY MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 110 TABLE 55 MASS SPECTROMETRY MARKET FOR RESEARCH LABS & ACADEMIC INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 111 TABLE 56 MASS SPECTROMETRY MARKET FOR ENVIRONMENTAL TESTING LABS, BY REGION, 2024–2031 (USD MILLION) 112 TABLE 57 MASS SPECTROMETRY MARKET FOR FOOD & BEVERAGE INDUSTRY, BY REGION, 2024–2031 (USD MILLION) 113 TABLE 58 MASS SPECTROMETRY MARKET FOR FORENSIC LABS, BY REGION, 2024–2031 (USD MILLION) 114 TABLE 59 MASS SPECTROMETRY MARKET FOR PETROCHEMICAL INDUSTRY, BY REGION, 2024–2031 (USD MILLION) 115 TABLE 60 MASS SPECTROMETRY MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 116 TABLE 61 MASS SPECTROMETRY MARKET, BY REGION, 2024–2031 (USD MILLION) 118 TABLE 62 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 63 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 120 TABLE 64 NORTH AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120 TABLE 65 NORTH AMERICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120 TABLE 66 NORTH AMERICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 121 TABLE 67 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY INLET TYPE, 2024–2031 (USD MILLION) 121 TABLE 68 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 122 TABLE 69 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY END USER, 2024–2031 (USD MILLION) 122 TABLE 70 US: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 123 TABLE 71 US: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 72 US: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 73 US: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 74 CANADA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 125 TABLE 75 CANADA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 125 TABLE 76 CANADA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 126 TABLE 77 CANADA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 126 TABLE 78 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 79 EUROPE: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 127 TABLE 80 EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 127 TABLE 81 EUROPE: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128 TABLE 82 EUROPE: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128 TABLE 83 EUROPE: MASS SPECTROMETRY MARKET, BY INLET TYPE, 2024–2031 (USD MILLION) 128 TABLE 84 EUROPE: MASS SPECTROMETRY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 129 TABLE 85 EUROPE: MASS SPECTROMETRY MARKET, BY END USER, 2024–2031 (USD MILLION) 129 TABLE 86 GERMANY: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 130 TABLE 87 GERMANY: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131 TABLE 88 GERMANY: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131 TABLE 89 GERMANY: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131 TABLE 90 UK: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 132 TABLE 91 UK: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133 TABLE 92 UK: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133 TABLE 93 UK: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133 TABLE 94 FRANCE: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 134 TABLE 95 FRANCE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134 TABLE 96 FRANCE: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135 TABLE 97 FRANCE: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135 TABLE 98 ITALY: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 136 TABLE 99 ITALY: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 100 ITALY: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 101 ITALY: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137 TABLE 102 SPAIN: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 137 TABLE 103 SPAIN: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 104 SPAIN: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 105 SPAIN: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 106 REST OF EUROPE: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 139 TABLE 107 REST OF EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139 TABLE 108 REST OF EUROPE: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140 TABLE 109 REST OF EUROPE: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140 TABLE 110 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 111 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 142 TABLE 112 ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 142 TABLE 113 ASIA PACIFIC: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 142 TABLE 114 ASIA PACIFIC: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 115 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY INLET TYPE, 2024–2031 (USD MILLION) 143 TABLE 116 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 144 TABLE 117 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY END USER, 2024–2031 (USD MILLION) 144 TABLE 118 JAPAN: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 145 TABLE 119 JAPAN: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 120 JAPAN: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE , 2024–2031 (USD MILLION) 146 TABLE 121 JAPAN: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 122 CHINA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 147 TABLE 123 CHINA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 124 CHINA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 125 CHINA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 126 INDIA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 149 TABLE 127 INDIA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 128 INDIA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 129 INDIA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 130 SOUTH KOREA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 151 TABLE 131 SOUTH KOREA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 132 SOUTH KOREA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 133 SOUTH KOREA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 134 AUSTRALIA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 153 TABLE 135 AUSTRALIA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154 TABLE 136 AUSTRALIA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154 TABLE 137 AUSTRALIA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154 TABLE 138 REST OF ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 155 TABLE 139 REST OF ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 155 TABLE 140 REST OF ASIA PACIFIC: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156 TABLE 141 REST OF ASIA PACIFIC: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156 TABLE 142 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 143 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 157 TABLE 144 LATIN AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 157 TABLE 145 LATIN AMERICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 158 TABLE 146 LATIN AMERICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 158 TABLE 147 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY INLET TYPE, 2024–2031 (USD MILLION) 158 TABLE 148 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 159 TABLE 149 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY END USER, 2024–2031 (USD MILLION) 159 TABLE 150 BRAZIL: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 160 TABLE 151 BRAZIL: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 160 TABLE 152 BRAZIL: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 153 BRAZIL: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 154 MEXICO: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 162 TABLE 155 MEXICO: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 162 TABLE 156 MEXICO: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 162 TABLE 157 MEXICO: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 163 TABLE 158 REST OF LATIN AMERICA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 163 TABLE 159 REST OF LATIN AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 164 TABLE 160 REST OF LATIN AMERICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 164 TABLE 161 REST OF LATIN AMERICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 164 TABLE 162 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 163 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 165 TABLE 164 MIDDLE EAST & AFRICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166 TABLE 165 MIDDLE EAST & AFRICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166 TABLE 166 MIDDLE EAST & AFRICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166 TABLE 167 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY INLET TYPE, 2024–2031 (USD MILLION) 167 TABLE 168 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 167 TABLE 169 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY END USER, 2024–2031 (USD MILLION) 168 TABLE 170 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 169 TABLE 171 GCC COUNTRIES: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 172 GCC COUNTRIES: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 173 GCC COUNTRIES: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 170 TABLE 174 REST OF MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 170 TABLE 175 REST OF MIDDLE EAST & AFRICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 176 REST OF MIDDLE EAST & AFRICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 177 REST OF MIDDLE EAST & AFRICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 178 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–JUNE 2026 173 TABLE 179 MASS SPECTROMETRY MARKET: DEGREE OF COMPETITION 175 TABLE 180 MASS SPECTROMETRY MARKET: OFFERING FOOTPRINT 179 TABLE 181 MASS SPECTROMETRY MARKET: APPLICATION FOOTPRINT 180 TABLE 182 MASS SPECTROMETRY MARKET: END-USER FOOTPRINT 181 TABLE 183 MASS SPECTROMETRY MARKET: REGION FOOTPRINT 182 TABLE 184 MASS SPECTROMETRY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 185 TABLE 185 MASS SPECTROMETRY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 186 TABLE 186 MASS SPECTROMETRY MARKET: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 190 TABLE 187 MASS SPECTROMETRY MARKET: DEALS, JANUARY 2022–JUNE 2026 192 TABLE 188 MASS SPECTROMETRY MARKET: EXPANSIONS, JANUARY 2022–JUNE 2026 193 TABLE 189 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 195 TABLE 190 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 196 TABLE 191 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2026 199 TABLE 192 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–JUNE 2026 200 TABLE 193 AGILENT TECHNOLOGIES INC.: EXPANSIONS, JANUARY 2022–JUNE 2026 201 TABLE 194 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 203 TABLE 195 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 204 TABLE 196 THERMO FISHER SCIENTIFIC, INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 206 TABLE 197 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2022–JUNE 2026 207 TABLE 198 THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS, JANUARY 2022–JUNE 2026 209 TABLE 199 WATERS CORPORATION: COMPANY OVERVIEW 211 TABLE 200 WATERS CORPORATION: PRODUCTS OFFERED 212 TABLE 201 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 214 TABLE 202 WATERS CORPORATION: DEALS, JANUARY 2022–JUNE 2026 215 TABLE 203 WATERS CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 216 TABLE 204 DANAHER CORPORATION: BUSINESS OVERVIEW 217 TABLE 205 DANAHER CORPORATION: PRODUCTS OFFERED 218 TABLE 206 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2026 220 TABLE 207 DANAHER CORPORATION: DEALS, JANUARY 2022–JUNE 2026 221 TABLE 208 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 221 TABLE 209 BRUKER CORPORATION: COMPANY OVERVIEW 223 TABLE 210 BRUKER CORPORATION: PRODUCTS OFFERED 224 TABLE 211 BRUKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2026 226 TABLE 212 BRUKER CORPORATION: DEALS, JANUARY 2022–JUNE 2026 227 TABLE 213 BRUKER CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 228 TABLE 214 BRUKER CORPORATION: OTHER DEVELOPMENTS 228 TABLE 215 SHIMADZU CORPORATION: COMPANY OVERVIEW 230 TABLE 216 SHIMADZU CORPORATION: PRODUCTS OFFERED 231 TABLE 217 SHIMADZU CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2026 233 TABLE 218 SHIMADZU CORPORATION: DEALS, JANUARY 2022–JUNE 2026 234 TABLE 219 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 235 TABLE 220 MKS INC.: COMPANY OVERVIEW 236 TABLE 221 MKS INC.: PRODUCTS OFFERED 237 TABLE 222 PERKINELMER, INC.: COMPANY OVERVIEW 238 TABLE 223 PERKINELMER, INC.: PRODUCTS OFFERED 239 TABLE 224 PERKINELMER, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2026 240 TABLE 225 PERKINELMER, INC.: DEALS, JANUARY 2022–JUNE 2026 241 TABLE 226 JEOL LTD.: COMPANY OVERVIEW 242 TABLE 227 JEOL LTD.: PRODUCTS OFFERED 243 TABLE 228 HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW 244 TABLE 229 HITACHI HIGH-TECH CORPORATION: PRODUCTS OFFERED 245 TABLE 230 HITACHI HIGH-TECH CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2026 246 TABLE 231 TELEDYNE TECHNOLOGIES INCORPORATED: COMPANY OVERVIEW 247 TABLE 232 TELEDYNE TECHNOLOGIES INCORPORATED: PRODUCTS OFFERED 248 TABLE 233 TELEDYNE TECHNOLOGIES INCORPORATED: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 249 TABLE 234 TELEDYNE TECHNOLOGIES INCORPORATED: DEALS, JANUARY 2022–JUNE 2026 249 TABLE 235 AMETEK, INC.: COMPANY OVERVIEW 250 TABLE 236 AMETEK, INC.: PRODUCTS OFFERED 251 TABLE 237 AMETEK, INC.: DEALS, JANUARY 2022–JUNE 2026 252 TABLE 238 JASCO: COMPANY OVERVIEW 253 TABLE 239 JASCO: PRODUCTS OFFERED 253 TABLE 240 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 254 TABLE 241 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 255 TABLE 242 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 256 TABLE 243 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2022–JUNE 2026 256 TABLE 244 ANALYTIK JENA GMBH: COMPANY OVERVIEW 257 TABLE 245 HIDEN ANALYTICAL: COMPANY OVERVIEW 258 TABLE 246 LECO CORPORATION: COMPANY OVERVIEW 259 TABLE 247 RIGAKU HOLDINGS CORPORATION: COMPANY OVERVIEW 260 TABLE 248 YOUNGIN CHROMASS: COMPANY OVERVIEW 261 TABLE 249 SCION INSTRUMENTS: COMPANY OVERVIEW 262 TABLE 250 KORE TECHNOLOGY: COMPANY OVERVIEW 263 TABLE 251 PROCESS INSIGHTS, INC.: COMPANY OVERVIEW 264 TABLE 252 MASSTECH: COMPANY OVERVIEW 265 TABLE 253 ADVION, INC.: COMPANY OVERVIEW 266 TABLE 254 SPACETEK TECHNOLOGY AG: COMPANY OVERVIEW 266 TABLE 255 ELEMENTAR ANALYSENSYSTEME GMBH: COMPANY OVERVIEW 267 TABLE 256 SKYRAY INSTRUMENTS USA, INC.: COMPANY OVERVIEW 268 TABLE 257 MICROSAIC SYSTEMS PLC: COMPANY OVERVIEW 269 TABLE 258 PFEIFFER VACUUM GMBH: COMPANY OVERVIEW 270 TABLE 259 MASS SPECTROMETRY MARKET: RISK ANALYSIS 285 FIGURE 1 MASS SPECTROMETRY MARKET SEGMENTATION AND REGIONAL SCOPE 27 FIGURE 2 MASS SPECTROMETRY MARKET: YEARS CONSIDERED 29 FIGURE 3 MARKET SCENARIO 31 FIGURE 4 MASS SPECTROMETRY MARKET, 2024–2031 31 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MASS SPECTROMETRY MARKET, 2023–2026 32 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF MASS SPECTROMETRY MARKET 33 FIGURE 7 HIGH-GROWTH SEGMENTS IN MASS SPECTROMETRY MARKET, 2026–2031 34 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 35 FIGURE 9 INCREASED DEMAND FOR ON-SITE TESTING TO DRIVE MARKET 36 FIGURE 10 LC-MS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 37 FIGURE 11 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031 38 FIGURE 12 MASS SPECTROMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39 FIGURE 13 MASS SPECTROMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 46 FIGURE 14 MASS SPECTROMETRY MARKET: VALUE CHAIN ANALYSIS 49 FIGURE 15 MASS SPECTROMETRY MARKET: ECOSYSTEM ANALYSIS 50 FIGURE 16 AVERAGE SELLING PRICE TREND OF MASS SPECTROMETERS, BY KEY PLAYER, 2023–2025 52 FIGURE 17 AVERAGE SELLING PRICE TREND OF MASS SPECTROMETERS, BY REGION, 2023–2025 54 FIGURE 18 IMPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 56 FIGURE 19 EXPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 57 FIGURE 20 NEW REVENUE POCKETS FOR PLAYERS IN MASS SPECTROMETRY MARKET 59 FIGURE 21 MASS SPECTROMETRY MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2023 (USD MILLION) 59 FIGURE 22 NUMBER OF DEALS IN MASS SPECTROMETRY MARKET, BY KEY PLAYER, 2019–2023 60 FIGURE 23 VALUE OF DEALS IN MASS SPECTROMETRY MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION) 60 FIGURE 24 MASS SPECTROMETRY MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2025 66 FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 75 FIGURE 26 KEY BUYING CRITERIA, BY END USER 75 FIGURE 27 NORTH AMERICA: MASS SPECTROMETRY MARKET SNAPSHOT 119 FIGURE 28 ASIA PACIFIC: MASS SPECTROMETRY MARKET SNAPSHOT 141 FIGURE 29 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MASS SPECTROMETRY MARKET, 2021–2025 174 FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MASS SPECTROMETRY MARKET, 2025 175 FIGURE 31 MASS SPECTROMETRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 177 FIGURE 32 MASS SPECTROMETRY MARKET: COMPANY FOOTPRINT 178 FIGURE 33 MASS SPECTROMETRY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 184 FIGURE 34 EV/EBITDA OF KEY VENDORS 187 FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 188 FIGURE 36 MASS SPECTROMETRY MARKET: BRAND COMPARATIVE ANALYSIS 189 FIGURE 37 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 196 FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 204 FIGURE 39 WATERS CORPORATION: COMPANY SNAPSHOT (2025) 212 FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 218 FIGURE 41 BRUKER CORPORATION: COMPANY SNAPSHOT (2025) 224 FIGURE 42 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025) 231 FIGURE 43 MKS INC.: COMPANY SNAPSHOT (2025) 237 FIGURE 44 PERKINELMER: COMPANY SNAPSHOT (2023) 239 FIGURE 45 JEOL: COMPANY SNAPSHOT (2025) 242 FIGURE 46 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT (2025) 245 FIGURE 47 TELEDYNE TECHNOLOGIES INCORPORATED: COMPANY SNAPSHOT (2025) 248 FIGURE 48 AMETEK, INC.: COMPANY SNAPSHOT (2025) 251 FIGURE 49 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 255 FIGURE 50 MASS SPECTROMETRY MARKET: RESEARCH DATA 271 FIGURE 51 MASS SPECTROMETRY MARKET: RESEARCH DESIGN 272 FIGURE 52 MASS SPECTROMETRY MARKET: KEY SECONDARY SOURCES 274 FIGURE 53 MASS SPECTROMETRY MARKET: KEY DATA FROM SECONDARY SOURCES 274 FIGURE 54 MASS SPECTROMETRY MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES) 275 FIGURE 55 MASS SPECTROMETRY MARKET: KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS 275 FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 276 FIGURE 57 MASS SPECTROMETRY MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 277 FIGURE 58 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 278 FIGURE 59 MASS SPECTROMETRY MARKET: COMPANY REVENUE ESTIMATION, 2025 280 FIGURE 60 MASS SPECTROMETRY MARKET: MARKET SIZE ESTIMATION METHODOLOGY 281 FIGURE 61 MASS SPECTROMETRY MARKET: GROWTH PROJECTIONS BASED ON REVENUE IMPACT OF KEY MACRO INDICATORS 282 FIGURE 62 DATA TRIANGULATION 283

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Mass Spectrometry Market by Product [Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software, Services], Inlet Type (LC-MS, GC-MS, ICP-MS, Other Inlet Types), Application (Omics, Drug Discovery, Food, Environmental), End User (Pharma, Biotech) - Global Forecast to 2031

授權報價

報告摘要

同分類最新報告（機械與設備）